Biosimilars
Biosimilars are medications that are similar, but not identical, to an already approved biological drug, known as a reference product. They are made from living organisms, like cells or bacteria, and are used to treat various diseases, including cancer and autoimmune disorders. Because they mimic the original drug, biosimilars can offer a potentially more affordable option for patients. However, they undergo rigorous testing to ensure they are safe and effective. While they are not exact copies due to the complex nature of biological products, they are expected to produce the same therapeutic results when administered to patients.
Additional Insights
-
Biosimilars are medications that are highly similar to an already approved biological drug, known as the "reference product." While they may have minor differences in clinically inactive components, biosimilars are designed to have the same safety, efficacy, and quality as the original drug. They are often used to treat complex conditions like cancer or autoimmune diseases. Because they are not exact replicas but rather similar versions, biosimilars can offer more affordable treatment options without compromising patient outcomes, ultimately making healthcare more accessible.